1. Home
  2. SLN vs EXFY Comparison

SLN vs EXFY Comparison

Compare SLN & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLN
  • EXFY
  • Stock Information
  • Founded
  • SLN 1994
  • EXFY 2008
  • Country
  • SLN United Kingdom
  • EXFY United States
  • Employees
  • SLN N/A
  • EXFY N/A
  • Industry
  • SLN Biotechnology: Pharmaceutical Preparations
  • EXFY Computer Software: Prepackaged Software
  • Sector
  • SLN Health Care
  • EXFY Technology
  • Exchange
  • SLN Nasdaq
  • EXFY Nasdaq
  • Market Cap
  • SLN 352.2M
  • EXFY 343.4M
  • IPO Year
  • SLN N/A
  • EXFY 2021
  • Fundamental
  • Price
  • SLN $5.12
  • EXFY $3.40
  • Analyst Decision
  • SLN Strong Buy
  • EXFY Buy
  • Analyst Count
  • SLN 4
  • EXFY 4
  • Target Price
  • SLN $61.50
  • EXFY $3.50
  • AVG Volume (30 Days)
  • SLN 460.0K
  • EXFY 367.2K
  • Earning Date
  • SLN 03-11-2025
  • EXFY 02-20-2025
  • Dividend Yield
  • SLN N/A
  • EXFY N/A
  • EPS Growth
  • SLN N/A
  • EXFY N/A
  • EPS
  • SLN N/A
  • EXFY N/A
  • Revenue
  • SLN $21,773,221.00
  • EXFY $137,440,000.00
  • Revenue This Year
  • SLN N/A
  • EXFY N/A
  • Revenue Next Year
  • SLN $104.98
  • EXFY $6.09
  • P/E Ratio
  • SLN N/A
  • EXFY N/A
  • Revenue Growth
  • SLN N/A
  • EXFY N/A
  • 52 Week Low
  • SLN $4.82
  • EXFY $1.24
  • 52 Week High
  • SLN $27.72
  • EXFY $4.13
  • Technical
  • Relative Strength Index (RSI)
  • SLN 25.52
  • EXFY 50.68
  • Support Level
  • SLN $4.82
  • EXFY $3.07
  • Resistance Level
  • SLN $7.87
  • EXFY $3.68
  • Average True Range (ATR)
  • SLN 0.62
  • EXFY 0.17
  • MACD
  • SLN -0.01
  • EXFY -0.04
  • Stochastic Oscillator
  • SLN 9.20
  • EXFY 54.10

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.

Share on Social Networks: